Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Forma Therapeutics : SVB Leerink Adjusts Forma Therapeutics Holdings PT to $54 From $65, Maintains Outperform Rating

06/11/2021 | 12:43pm EDT


© MT Newswires 2021
All news about FORMA THERAPEUTICS HOLDINGS, INC.
10/07FORMA THERAPEUTICS : Shares Fall After it Releases Prostate Cancer Study Data
MT
10/07FORMA THERAPEUTICS : Says FT-7051 Showed Therapeutic Potential in Prostate Cancer Study
MT
10/07FORMA THERAPEUTICS' : FT-7051 is Well-tolerated and Demonstrates Evidence of Activity in I..
PU
10/07FORMA THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Other Events (form 8-K)
AQ
10/07FORMA THERAPEUTICS : rsquo; FT-7051 is Well-tolerated and Demonstrates Evidence of Activit..
BU
10/07Forma Therapeutics Holdings, Inc. Announces Positive Initial Results from A Phase 1 Tri..
CI
09/17FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
08/17FORMA THERAPEUTICS : HC Wainwright Adjusts Price Target on Forma Therapeutics Holdings to ..
MT
08/13FORMA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/13FORMA THERAPEUTICS' : Q2 Loss Narrows, Operating Expenses Rise
MT
More news
Analyst Recommendations on FORMA THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7,14 M - -
Net income 2021 -166 M - -
Net cash 2021 484 M - -
P/E ratio 2021 -5,04x
Yield 2021 -
Capitalization 833 M 833 M -
EV / Sales 2021 48,9x
EV / Sales 2022 159x
Nbr of Employees 139
Free-Float 92,2%
Chart FORMA THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Forma Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORMA THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 17,59 $
Average target price 56,29 $
Spread / Average Target 220%
EPS Revisions
Managers and Directors
Frank D. Lee President, Chief Executive Officer & Director
Todd E. Shegog Chief Financial Officer & Senior Vice President
Peter Wirth Chairman
David N. Cook Chief Scientific Officer & Senior Vice President
Patrick Kelly Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
FORMA THERAPEUTICS HOLDINGS, INC.-49.60%833
MODERNA, INC.220.51%135 157
LONZA GROUP AG27.29%58 232
IQVIA HOLDINGS INC.38.67%47 608
SEAGEN INC.-1.81%31 287
CELLTRION, INC.-39.69%24 952